Community Programs

Numerous resources are available to aid in
expanding public awareness and education.

In response to a growing need for education, awareness, and training resources around opioids and opioid safety, various community programs are available for qualified entities. This includes grants to professional and community-based organizations for educational efforts about opioid abuse and the risks of opioid medications in the community.

NARCAN® (naloxone HCl) Nasal Spray Public Libraries Program

Public libraries in the United States are eligible to receive 1 carton of NARCAN® Nasal Spray (2 doses) along with educational materials to facilitate Opioid Awareness Training for the community.

Opioid Awareness Education is available here.

For ordering information, please download the form in the link below and send to communityprograms@ebsi.com or call 1-844-4-NARCAN (1-844-462-7226).

Public Library Order Form

NARCAN® Nasal Spray YMCA Program

The Y is a leading nonprofit, strengthening community through youth development, healthy living, and social responsibility. The makers of NARCAN® Nasal Spray are proud to work with the Y in support of its mission. Through this collaboration, every YMCA is eligible to receive 1 carton of NARCAN® Nasal Spray (2 doses) and educational material at no cost.

Opioid Awareness Education is available here.

For ordering information, please download the form in the link below and send to communityprograms@ebsi.com or call 1-844-4-NARCAN (1-844-462-7226). Please provide the official name of your YMCA Association and your Corporate Association Number with your request.

YMCA Order Form

NARCAN® Nasal Spray Schools Program

High schools, colleges, and universities, in addition to other organizations, can play a crucial role to change the course of the opioid overdose epidemic. Each State Department of Education or individual school can prepare high schools, colleges, and universities across the country for an opioid overdose emergency by stocking NARCAN® Nasal Spray. In an effort to support this cause, every high school throughout the country has access to 2 cartons of Nasal Spray (4 doses) and up to 4 cartons (8 doses) for Title IV, degree-granting, 2- and 4-year institutions at no cost.

Through an educational grant to the National Association of School Nurses (NASN), a free Naloxone in Schools Toolkit was developed to assist school nurses in educating students, parents, faculty, staff, and all community stakeholders about the risks of prescription and illicit opioid medications in the community.

The free (NASN) Naloxone in Schools Toolkit is available here.

For ordering information, please download the form in the link below and send to communityprograms@ebsi.com or call 1-844-4-NARCAN (1-844-462-7226).

High School Order Form

Colleges & Universities Order Form

Minnesota Multistate Contracting Alliance for Pharmacy (MMCAP)

Emergent BioSolutions, in partnership with Minnesota Multistate Contracting Alliance for Pharmacy (MMCAP), offers NARCAN® Nasal Spray to approved MMCAP members at a discounted, contracted price. For more information, please contact Emergent BioSolutions at 1-844-462-7226.

MMCAP membership is open to government entities. More information can be found at www.mmcap.org.

MMCAP members, click here to download the Declaration Form.

INDICATION AND IMPORTANT SAFETY INFORMATION

NARCAN® (naloxone HCl) Nasal Spray is used for the treatment of an opioid emergency or a possible opioid overdose with signs of breathing problems and severe sleepiness or not being able to respond. NARCAN® Nasal Spray is to be given right away and does not take the place of emergency medical care. Get emergency medical help right away after giving the first dose of NARCAN® Nasal Spray, even if the person wakes up because symptoms may return. Repeat doses may be necessary.

Do not use NARCAN® Nasal Spray if you are allergic to naloxone hydrochloride or any of the ingredients in NARCAN® Nasal Spray.

What is the most important information I should know about NARCAN® Nasal Spray?
NARCAN® Nasal Spray is used to temporarily reverse the effects of opioid medicines. The medicine in NARCAN® Nasal Spray has no effect in people who are not taking opioid medicines.

Use NARCAN® Nasal Spray right away if you or your caregiver think signs or symptoms of an opioid emergency are present, even if you are not sure, because an opioid emergency can cause severe injury or death.

Family members, caregivers, or other people who may have to use NARCAN® Nasal Spray in an opioid emergency should know where NARCAN® Nasal Spray is stored and how to give NARCAN® before an opioid emergency happens.

Get emergency medical help right away after giving the first dose of NARCAN® Nasal Spray.
Rescue breathing or CPR (cardiopulmonary resuscitation) may be given while waiting for emergency medical help.

The signs and symptoms of an opioid emergency can return after NARCAN® Nasal Spray is given. If this happens, give another dose after 2 to 3 minutes using a new NARCAN® Nasal Spray and watch the person closely until emergency help is received.

NARCAN® Nasal Spray may cause serious side effects, including sudden opioid withdrawal symptoms.
Opioid withdrawal symptoms may include body aches, diarrhea, increased heart rate, fever, runny nose, sneezing, goose bumps, sweating, yawning, nausea or vomiting, nervousness, restlessness or irritability, shivering or trembling, stomach cramping, weakness, increased blood pressure.

In infants under 4 weeks old who have been receiving opioids regularly, sudden opioid withdrawal may be life-threatening if not treated the right way. Signs and symptoms include: seizures, crying more than usual, and increased reflexes.

These are not all of the possible side effects of NARCAN® Nasal Spray. Call your doctor for medical advice about side effects.
To report SUSPECTED ADVERSE REACTIONS, contact ADAPT Pharma, Inc. at 1-844-4NARCAN (1-844-462-7226) or FDA at 1-800-FDA-1088 or
www.fda.gov/medwatch.

Please see full Prescribing Information.

References: 1. U.S. Surgeon General's advisory on naloxone and opioid overdose. U.S. Department of Health and Human Services website. https://www.surgeongeneral.gov/priorities/opioid-overdose-prevention/naloxone-advisory.html. Accessed April 14, 2020. 2. Rudd RA, Seth P, David F, Scholl L. Increases in drug and opioid-involved overdose deaths — United States, 2010–2015. Morb Mortal Wkly Rep. 2016;65(50-51):1445–1452. 3. Elzey MJ, Barden SM, Edwards ES. Patient characteristics and outcomes in unintentional, non-fatal prescription opioid overdoses: a systematic review. Pain Physician. 2016;19:215-228. 4. 7 staggering statistics about America's opioid epidemic. ChoosePT website. https://www.choosept.com/resources/detail/7-staggering-statistics-about-america-s-opioid-epi. Accessed April 28, 2020. 5. Results from the 2016 national survey on drug use and health: detailed tables. Substance Abuse and Mental Health Services Administration website. https://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs-2016/NSDUH-DetTabs-2016.pdf. Accessed April 14, 2020. 6. Sun EC, Jena AB. Distribution of prescription opioid use among privately insured adults without cancer: United States, 2001 to 2013. Ann Intern Med. 2017;167(9):684-686. 7. The next gateway drug: how prescription drugs have started a new epidemic, March 19, 2018. DISA Global Solutions website. https://disa.com/blog/the-next-gateway-drug-how-prescription-drugs-have-started-a-new-epidemic. Accessed April 28, 2020. 8. McCance-Katz EF. The National Survey on Drug Use and Health: 2017. Substance Abuse and Mental Health Services Administration website. https://www.samhsa.gov/data/sites/default/files/nsduh-ppt-09-2018.pdf. Accessed April 15, 2020. 9. NARCAN® Nasal Spray [prescribing information]. Plymouth Meeting, PA: ADAPT Pharma, Inc.; 2020.

INDICATION AND IMPORTANT SAFETY INFORMATION

NARCAN® (naloxone HCl) Nasal Spray is used for the treatment of an opioid emergency or a possible opioid overdose with signs of breathing problems and severe sleepiness or not being able to respond. NARCAN® Nasal Spray is to be given right away and does not take the place of emergency medical care. Get emergency medical help right away after giving the first dose of NARCAN® Nasal Spray, even if the person wakes up because symptoms may return. Repeat doses may be necessary.

Do not use NARCAN® Nasal Spray if you are allergic to naloxone hydrochloride or any of the ingredients in NARCAN® Nasal Spray.

What is the most important information I should know about NARCAN® Nasal Spray?
NARCAN® Nasal Spray is used to temporarily reverse the effects of opioid medicines. The medicine in NARCAN® Nasal Spray has no effect in people who are not taking opioid medicines.

Use NARCAN® Nasal Spray right away if you or your caregiver think signs or symptoms of an opioid emergency are present, even if you are not sure, because an opioid emergency can cause severe injury or death.

Family members, caregivers, or other people who may have to use NARCAN® Nasal Spray in an opioid emergency should know where NARCAN® Nasal Spray is stored and how to give NARCAN® before an opioid emergency happens.

Get emergency medical help right away after giving the first dose of NARCAN® Nasal Spray.
Rescue breathing or CPR (cardiopulmonary resuscitation) may be given while waiting for emergency medical help.

The signs and symptoms of an opioid emergency can return after NARCAN® Nasal Spray is given. If this happens, give another dose after 2 to 3 minutes using a new NARCAN® Nasal Spray and watch the person closely until emergency help is received.

NARCAN® Nasal Spray may cause serious side effects, including sudden opioid withdrawal symptoms.
Opioid withdrawal symptoms may include body aches, diarrhea, increased heart rate, fever, runny nose, sneezing, goose bumps, sweating, yawning, nausea or vomiting, nervousness, restlessness or irritability, shivering or trembling, stomach cramping, weakness, increased blood pressure.

In infants under 4 weeks old who have been receiving opioids regularly, sudden opioid withdrawal may be life-threatening if not treated the right way. Signs and symptoms include: seizures, crying more than usual, and increased reflexes.

These are not all of the possible side effects of NARCAN® Nasal Spray. Call your doctor for medical advice about side effects.
To report SUSPECTED ADVERSE REACTIONS, contact ADAPT Pharma, Inc. at 1-844-4NARCAN (1-844-462-7226) or FDA at 1-800-FDA-1088 or
www.fda.gov/medwatch.

Please see full Prescribing Information.

References: 1. U.S. Surgeon General's advisory on naloxone and opioid overdose. U.S. Department of Health and Human Services website. https://www.surgeongeneral.gov/priorities/opioid-overdose-prevention/naloxone-advisory.html. Accessed April 14, 2020. 2. Rudd RA, Seth P, David F, Scholl L. Increases in drug and opioid-involved overdose deaths — United States, 2010–2015. Morb Mortal Wkly Rep. 2016;65(50-51):1445–1452. 3. Elzey MJ, Barden SM, Edwards ES. Patient characteristics and outcomes in unintentional, non-fatal prescription opioid overdoses: a systematic review. Pain Physician. 2016;19:215-228. 4. 7 staggering statistics about America's opioid epidemic. ChoosePT website. https://www.choosept.com/resources/detail/7-staggering-statistics-about-america-s-opioid-epi. Accessed April 28, 2020. 5. Results from the 2016 national survey on drug use and health: detailed tables. Substance Abuse and Mental Health Services Administration website. https://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs-2016/NSDUH-DetTabs-2016.pdf. Accessed April 14, 2020. 6. Sun EC, Jena AB. Distribution of prescription opioid use among privately insured adults without cancer: United States, 2001 to 2013. Ann Intern Med. 2017;167(9):684-686. 7. The next gateway drug: how prescription drugs have started a new epidemic, March 19, 2018. DISA Global Solutions website. https://disa.com/blog/the-next-gateway-drug-how-prescription-drugs-have-started-a-new-epidemic. Accessed April 28, 2020. 8. McCance-Katz EF. The National Survey on Drug Use and Health: 2017. Substance Abuse and Mental Health Services Administration website. https://www.samhsa.gov/data/sites/default/files/nsduh-ppt-09-2018.pdf. Accessed April 15, 2020. 9. NARCAN® Nasal Spray [prescribing information]. Plymouth Meeting, PA: ADAPT Pharma, Inc.; 2020.